These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1286574)

  • 1. Incidence of beta-lactamase production among out patient clinical isolates in Middle Eastern countries and their antibiotic susceptibilities. Middle Eastern Study Group.
    Shibl AM
    Chemotherapy; 1992; 38(5):324-9. PubMed ID: 1286574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study.
    Fajfr M; Louda M; Paterová P; Ryšková L; Pacovský J; Košina J; Žemličková H; Broďák M
    BMC Urol; 2017 Apr; 17(1):33. PubMed ID: 28446177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactamase production and the role of ampicillin/sulbactam.
    Alpuche-Aranda CM
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
    Cullmann W; Dick W; Stieglitz M; Opferkuch W
    Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of several antibiotics on pathogenic micro-organisms isolated from the lower respiratory tract].
    Allocco A; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1994; 86(1-12):15-28. PubMed ID: 8706972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of antimicrobial resistance to oral antibiotics in Italy.
    Cullmann W
    Chemotherapy; 1993; 39(1):13-21. PubMed ID: 8444057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-lactamase production and the patterns of bacterial resistance, 1988-1991].
    Rodríguez Noriega E; Morfín Otero R; Esparza Ahumada S
    Gac Med Mex; 1994; 130(5):355-60. PubMed ID: 7607365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence and resistance patterns of pathogens from lower respiratory tract infections (LRTI)].
    Dorobăţ OM; Moisoiu A; Tălăpan D
    Pneumologia; 2007; 56(1):7-15. PubMed ID: 17491203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
    Yenn TW; Arslan Khan M; Amiera Syuhada N; Chean Ring L; Ibrahim D; Tan WN
    Steroids; 2017 Dec; 128():68-71. PubMed ID: 29104098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of beta-lactamases in Africa: correlation with resistance to beta-lactam antibiotics.
    Dowse LJ; Prigent BM
    Clin Ther; 1991; 13(2):243-53. PubMed ID: 1863940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies with Bay V 3522, a new oral cephalosporin.
    Thomson KS; Sanders CC; Sanders WE
    Drugs Exp Clin Res; 1991; 17(3):165-73. PubMed ID: 1914843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of β-lactamase-producing bacteria in human periodontitis.
    Rams TE; Degener JE; van Winkelhoff AJ
    J Periodontal Res; 2013 Aug; 48(4):493-9. PubMed ID: 23173872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of extended spectrum beta lactamase mediated resistance in neonatal septicemia.
    Vinodkumar CS; Neelagund YF
    Indian J Pathol Microbiol; 2006 Oct; 49(4):616-9. PubMed ID: 17183878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of antibiotics treatment in 86 cases of liver transplant recipients].
    Liu ZG; Gong HY; Zhou JD; Zhang HY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):852-5. PubMed ID: 19958647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study.
    Rossolini GM; Dryden MS; Kozlov RS; Quintana A; Flamm RK; Läuffer JM; Lee E; Morrissey I; CLASS Study Group
    J Antimicrob Chemother; 2011 Jan; 66(1):151-9. PubMed ID: 21051375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of extended spectrum beta lactamase in urinary isolates.
    Tankhiwale SS; Jalgaonkar SV; Ahamad S; Hassani U
    Indian J Med Res; 2004 Dec; 120(6):553-6. PubMed ID: 15654142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.